Clinical trial Recruiting at 1 site Observational Ages 3 to 10

Follow-up on children from the TEMPO study regarding allergies and infections

Official title: A Virtual, Decentralised Observational Follow-up Study Investigating Feeding Patterns in Infancy and the Associated Parent-reported Allergic Manifestations, Allergies and Infections in Childhood.

Run by Nutricia Research · NCT05449756 · Data updated 2026-11-12

This study is following children from the TEMPO study to see how their early feeding habits affect their chances of developing allergies and infections as they grow up.

More Allergy trials

Quick facts

Study typeObservational
Ages3 Years to 10 Years
SexAll
Enrollment705 (estimated)
SponsorNutricia Research
Industry-sponsored
Locations1 site (Beek)
StatusRecruiting
StartedMay 30, 2023
Main results expectedMarch 31, 2029
Study endsMarch 31, 2029
Registry record updatedDecember 11, 2023
Trial IDNCT05449756 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children who completed the TEMPO study and whose parents consent to participate in the follow-up.

Probably not a fit

Patients whose parents do not have access to the necessary technology for participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows children who participated in the TEMPO study during their first year of life to assess the development of allergies and infections as they grow. The study aims to understand the relationship between their infant feeding patterns, including the consumption of infant formula and human breast milk, and subsequent health outcomes. Participants will complete self-administered questionnaires to provide data on their health status. The findings may help inform future guidelines on infant nutrition and health.

Why it matters

Potential benefit: If successful, this study could provide insights into how early feeding practices influence the risk of allergies and infections in childhood.

How similar studies have gone: Similar studies have shown promising results in understanding the impact of early nutrition on long-term health outcomes, suggesting this approach has potential.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects are eligible to participate in the TEMPO Follow-Up study in case:
* they completed the final (12 months) visit in the TEMPO study.
* parents agree that their contact details will be shared with a third party for study purposes.
* parents agree that data collected in the TEMPO study will be used in the TEMPO Follow-Up study.
* parents provide written informed consent for participation in the TEMPO Follow-Up in accordance with local law.

Exclusion Criteria:

* Parents who do not have a smartphone, tablet or personal computer with internet access.

Where it's running

  • PreCare Trial & Recruitment
    Beek, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • What the Mayo Clinic is learning from blood clot tests in allergic reactions

    This study tests whether real-time blood clotting markers can help understand and predict the severity of allergic reactions and anaphylaxis in patients 12 and older.

    Recruiting Mayo Clinic · Rochester, Minnesota · NCT07905911

  • Does having allergic parents raise the chance of bronchiolitis in babies by 12 months?

    We’re testing if infants with at least one allergic parent are more likely to have bronchiolitis by 12 months compared to infants whose parents have no allergies.

    Recruiting Centre Hospitalier Universitaire, Amiens · Amiens, Picardie · NCT07832643

  • Using alpha-gal KO pork to see if it reduces reactions in people with Alpha-gal Syndrome

    This study tests whether eating pork that lacks the alpha-gal allergen lowers reaction risk for people with Alpha-gal Syndrome, using a crossover design where each participant tries both KO and wild-type pork on separate days.

    Recruiting Phase 2 National Institute of Allergy and Infectious Diseases (NIAID) · Little Rock, Arkansas and 3 other locations · NCT07611435

  • Lymph node examination during cat allergy immunotherapy

    This project will test how lymph nodes react after a small cat allergen skin challenge in people with cat allergy who are either on long-term allergy shots or have never had immunotherapy.

    Recruiting Early Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · Boston, Massachusetts · NCT07447869

  • How classroom indoor air affects children's allergies and wellbeing

    This project will test whether continuous classroom and home air pollutant monitoring can identify pollution patterns linked to worse allergy or asthma symptoms in school-age children.

    Recruiting University Hospital, Montpellier · Montpellier · NCT07402200

  • Beltaven shots for allergy to honeybee, paper wasp, or yellow jacket

    This project will try subcutaneous Beltaven allergy shots in people aged 14 and up who have had systemic reactions to Apis mellifera, Polistes dominula, or Vespula stings to see if they are safe and helpful in routine care.

    Recruiting at 13 sites Probelte Pharma S.L.U. · Barcelona, Barcelona and 12 other locations · NCT07309822

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.